Brief: Dynasil Announces Submission Of Xcede Technologies' Application For First-In-Human Clinical Trial
Jan 11 (Reuters) - Dynasil Corporation Of America DYSL.O :
* DYNASIL ANNOUNCES SUBMISSION OF XCEDE TECHNOLOGIES'
APPLICATION
FOR FIRST-IN-HUMAN CLINICAL TRIAL
* DYNASIL CORPORATION OF AMERICA - ANTICIPATES THAT
PATIENTS WILL
BE TREATED WITH XCEDE PATCH IN NETHERLANDS IN EARLY 2018
Source text for Eikon: ID:nPn5LgGnFa
Further company coverage: DYSL.O
((Bangalore.newsroom@thomsonreuters.com;))